Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study
Open Access
- 1 June 2026
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-16
Abstract
Purpose: To evaluate the intraocular pressure (IOP)-lowering efficacy and adverse event profile of Xen63 gel stent compared to the Preserflo microshunt. Methods: Retrospective, multicenter, two-arm cohort study comparing 65 eyes undergoing standalone Xen63 implantation and 75 eyes undergoing standalone Preserflo implantation, all with intraoperative mitomycin C (MMC). Primary outcome was complete success, defined as all of the followings: 1) no two consecutive IOP readings > 17mmHg, 2) ≥ 20% IOP reduction from baseline; 3) no clinical hypotony (IOP < 6 mmHg associated with loss of ≥ 2 lines of vision); and 4) no use of glaucoma medications. Secondary outcomes included success at different IOP cut offs, qualified success (allowing medications), change in IOP, medications, complications, interventions, and re-operations. Results: At 12 months, complete success was achieved in 61.5% of eyes in the Xen63 group and 73.9% in the Preserflo group (p = 0.13). Postoperative complications were more frequent in the Xen63 group compared with the Preserflo group (61.5% vs. 29.3%, p = 0.0002). Postoperative interventions were required at similar rates between groups (Xen63 30.8% vs. Preserflo 28.0%, p = 0.85); however, reoperations were performed more frequently in the Xen63 group (16.9% vs. 4.0%, p = 0.01). Non-Caucasian ethnicity was associated with an increased risk of surgical failure (HR 2.57; 95% CI, 1.26– 5.23). Conclusion: Both devices achieved comparable success rates, median IOP reduction, and postoperative medication burden; however, the Xen63 group experienced a higher rate of complications and reoperations.Keywords
This publication has 28 references indexed in Scilit:
- Glaucoma Surgery Comparison: SIBS Microshunt Versus Gelatin 45 µm Microstent Versus Trabeculectomy as Primary Surgical InterventionsAmerican Journal of Ophthalmology, 2025
- All Consecutive Ab Externo SIBS Microshunt Implantations With Mitomycin C: One-Year Outcomes and Risk Factors for FailureAmerican Journal of Ophthalmology, 2023
- Intermediate Outcomes of the Novel 63-μm Gelatin Microstent versus the Conventional 45-μm Gelatin MicrostentOphthalmology Glaucoma, 2023
- Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle GlaucomaOphthalmology Glaucoma, 2023
- Gel Stent Versus Trabeculectomy: The Randomized, Multicenter, Gold-Standard Pathway Study (GPS) of Effectiveness and Safety at 12 MonthsAmerican Journal of Ophthalmology, 2023
- Standalone Ab Interno Gelatin Stent versus TrabeculectomyOphthalmology Glaucoma, 2018
- Observational Outcomes of Initial Trabeculectomy With Mitomycin C in Patients of African Descent vs Patients of European DescentJAMA Ophthalmology, 2018
- The development of a micro‐shunt made from poly(styrene‐block‐isobutylene‐block‐styrene) to treat glaucomaJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2015
- Ab interno approach to the subconjunctival space using a collagen glaucoma stentJournal of Cataract & Refractive Surgery, 2014
- A Newly Designed Glaucoma Drainage Implant Made of Poly(styrene-b-isobutylene-b-styrene)Archives of Ophthalmology (1950), 2006